Výsledky vyhledávání

Akademický článek

Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges.

Autor: Jakob Gubensek, Alesa Orsag, Rafael Ponikvar, Jadranka Buturovic-Ponikvar

Publikováno v: PLoS ONE, Vol 11, Iss 12, p e0168593 (2016)

Regional citrate anticoagulation (RCA) during hemodialysis interferes with calcium homeostasis. Optimal ionized calcium (iCa) target range during RCA and consequent calcium balance are unknown.In a randomized controlled trial (ACTRN12613001029785) 30

Externí odkaz: https://doaj.org/article/fd0fb1890f81444fac4d947b4d8b7d38

Zobrazit plný text záznamu

Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis—A Randomized Trial

Autor: Jakob Gubensek, Saša Simčič, Mojca Bozic-Mijovski, Alesa Orsag, Samo Hudoklin

Publikováno v: Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 2987, p 2987 (2021)
Volume 10
Issue 13

Background: The dose of citrate needed in regional citrate anticoagulation (RCA) to achieve optimal biocompatibility is unknown. We performed a randomized trial comparing two doses (ACTRN12613001340729). Methods: In 30 patients a single hemodialysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39811c007e49947083425d839691ac01
http://europepmc.org/articles/PMC8268353

Zobrazit plný text záznamu

Plný text ve formátu HTML

P1069COMPARISON OF BIOCOMPATIBILITY OF REGULAR AND INCREASED DOSE OF CITRATE IN CHRONIC HEMODIALYSIS - PRELIMINARY RESULTS OF A RANDOMIZED TRIAL

Autor: Jakob Gubensek, Mojca Bozic-Mijovski, Saša Simčič, Alesa Orsag

Publikováno v: Nephrology Dialysis Transplantation. 35

Background and Aims The dose of citrate that is needed in regional citrate anticoagulation (RCA) to achieve optimal biocompatibility of the extracorporeal circuit is not known. Insufficient biocompatibility is related with increased inflammation and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8594434b59398d6526dbbebe44ad5122
https://doi.org/10.1093/ndt/gfaa142.p1069

Zobrazit plný text záznamu

Rituximab for the treatment of membranous nephropathy: a single-center experience

Autor: Andrej Škoberne, Željka Večerić Haler, Andreja Aleš Rigler, Damjan Kovač, Radoslav Kveder, Špela Borštnar, Alenka Vizjak, Jelka Lindič, Alexander Jerman, Nuša Avguštin, Alesa Orsag, Nika Kojc, Dušan Ferluga

Publikováno v: Clinical Nephrology. 88:27-31

Background Treatment of idiopathic membranous nephropathy with rituximab was introduced more than a decade ago following experimental data that suggested involvement of B-cell-mediated reactions in its pathogenesis. It was a logical step towards a mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1a9d6dfe3370cc3139eb29b314c047
https://doi.org/10.5414/cnp88fx07

Zobrazit plný text záznamu

Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges

Autor: Rafael Ponikvar, Jakob Gubensek, Jadranka Buturović-Ponikvar, Alesa Orsag

Publikováno v: PLoS ONE, Vol 11, Iss 12, p e0168593 (2016)
PLoS ONE

Background Regional citrate anticoagulation (RCA) during hemodialysis interferes with calcium homeostasis. Optimal ionized calcium (iCa) target range during RCA and consequent calcium balance are unknown. Methods In a randomized controlled trial (ACT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7097f6f7896a663d3c6dbb8306ecb6c2
http://europepmc.org/articles/PMC5193410?pdf=render

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání